Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of dopamine in the brain - lessons learned from Parkinson's disease
David Meder, Damian M. Herz, James B. Rowe, et al.
NeuroImage (2018) Vol. 190, pp. 79-93
Open Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

Current Understanding of Hydrogel for Drug Release and Tissue Engineering
Lanjie Lei, Yujing Bai, Xinyun Qin, et al.
Gels (2022) Vol. 8, Iss. 5, pp. 301-301
Open Access | Times Cited: 94
Alterations in GABAA-Receptor Trafficking and Synaptic Dysfunction in Brain Disorders
Miranda Mele, Rui O. Costa, Carlos B. Duarte
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 83
What do reinforcement learning models measure? Interpreting model parameters in cognition and neuroscience
Maria K. Eckstein, Linda Wilbrecht, Anne Collins
Current Opinion in Behavioral Sciences (2021) Vol. 41, pp. 128-137
Open Access | Times Cited: 83
Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson’s Disease: a Systematic Review
Michele Goulart dos Santos, Lúcia Emanueli Schimith, Corinne André‐Miral, et al.
Neurotoxicity Research (2022) Vol. 40, Iss. 1, pp. 319-345
Closed Access | Times Cited: 48
Adipose tissue, systematic inflammation, and neurodegenerative diseases
Ludovico Migliolo, AnaPaula de A. Boleti, Pedro Henrique de Oliveira Cardoso, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 1, pp. 38-38
Open Access | Times Cited: 44
Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
Yumin Wang, Shuang Wu, Qiang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 42
Plasmonic Coupling on an Optical Microfiber Surface: Enabling Single‐Molecule and Noninvasive Dopamine Detection
Yunyun Huang, Pengwei Chen, Luyan Zhou, et al.
Advanced Materials (2023) Vol. 35, Iss. 33
Closed Access | Times Cited: 25
Recent Prospects of Carbonaceous Nanomaterials-Based Laccase Biosensor for Electrochemical Detection of Phenolic Compounds
Sakshi Verma, Deeksha Thakur, Chandra Mouli Pandey, et al.
Biosensors (2023) Vol. 13, Iss. 3, pp. 305-305
Open Access | Times Cited: 23
Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction
Masaru Tanaka, László Vécsei
Journal of Neural Transmission (2024) Vol. 131, Iss. 12, pp. 1367-1387
Open Access | Times Cited: 9
Cells, pathways, and models in dyskinesia research
M. Angela Cenci, Arvind Kumar
Current Opinion in Neurobiology (2024) Vol. 84, pp. 102833-102833
Open Access | Times Cited: 8
Wireless, Battery-Free Implants for Electrochemical Catecholamine Sensing and Optogenetic Stimulation
Tucker Stuart, William J. Jeang, Richard A. Slivicki, et al.
ACS Nano (2022) Vol. 17, Iss. 1, pp. 561-574
Closed Access | Times Cited: 34
Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes
Frank H. Hezemans, Noham Wolpe, Claire O’Callaghan, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 5, pp. e1010079-e1010079
Open Access | Times Cited: 33
A literature review of dopamine in binge eating
Yang Yu, Renee M. Miller, Susan W. Groth
Journal of Eating Disorders (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 32
Moving, fast and slow: behavioural insights into bradykinesia in Parkinson’s disease
Damian M. Herz, Peter Brown
Brain (2023) Vol. 146, Iss. 9, pp. 3576-3586
Open Access | Times Cited: 20
Iron Single‐Atom Catalysts on MXenes for Ultrasensitive Monitoring of Adrenal Tumor Markers and Cellular Dopamine
Saptami Suresh Shetty, Jehad K. El‐Demellawi, Yusuf Khan, et al.
Advanced Materials Technologies (2023) Vol. 8, Iss. 6
Closed Access | Times Cited: 16
Integrated physiological, intestinal microbiota, and metabolomic responses of adult zebrafish (Danio rerio) to subacute exposure to antimony at environmentally relevant concentrations
Can Liu, Dongmei Huang, Xiangquan Sheng, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 277, pp. 116326-116326
Open Access | Times Cited: 6
Application of Nanobiosensor Engineering in the Diagnosis of Neurodegenerative Disorders
Thikra S. Dhahi, Alaa Kamal Yousif Dafhalla, A. Wesam Al-Mufti, et al.
Results in Engineering (2024) Vol. 24, pp. 102790-102790
Open Access | Times Cited: 6
Putamen gray matter volumes in neuropsychiatric and neurodegenerative disorders.
Xingguang Luο, Qiao Mao, Jing Shi, et al.
PubMed (2019) Vol. 3, Iss. 1
Closed Access | Times Cited: 52
Brain Motor Network Changes in Parkinson's Disease: Evidence from Meta‐Analytic Modeling
Damian M. Herz, David Meder, Julia A. Camilleri, et al.
Movement Disorders (2021) Vol. 36, Iss. 5, pp. 1180-1190
Open Access | Times Cited: 36
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1897-1897
Open Access | Times Cited: 35
Role of dopamine and clinical heterogeneity in cognitive dysfunction in Parkinson's disease
Roshan Cools, Jorryt Tichelaar, Rick C. Helmich, et al.
Progress in brain research (2022), pp. 309-343
Open Access | Times Cited: 27
Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease
Jingru Ren, Lei Yan, Hao Zhou, et al.
Neurobiology of Disease (2023) Vol. 185, pp. 106254-106254
Open Access | Times Cited: 14
HDAC4/5 Inhibitor, LMK‐235 Improves Animal Voluntary Movement in MPTP‐Induced Parkinson's Disease Model
Heejin Lee, Hyun‐Jin Kim, Ju‐Sik Min, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access
Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial
Joaquim J. Ferreira, Miguel Gago, Raquel Costa, et al.
Journal of Parkinson s Disease (2025)
Open Access
Increased incidence of Akinetic Crises in Parkinson’s disease patients treated with Levodopa-Carbidopa Intestinal Gel: a case series and review of the literature.
Alexandros Giannakis, Konstantinos I. Tsamis, Spiridon Konitsiotis
Clinical Neurology and Neurosurgery (2025) Vol. 249, pp. 108777-108777
Closed Access
Page 1 - Next Page

Scroll to top